Cargando…

Deconvoluting Chronic Obstructive Pulmonary Disease: Are B Cells the Frontrunners?

Detalles Bibliográficos
Autor principal:	Polverino, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515871/ https://www.ncbi.nlm.nih.gov/pubmed/30633537 http://dx.doi.org/10.1164/rccm.201811-2093LE

Ejemplares similares

Reply to Polverino: Deconvoluting Chronic Obstructive Pulmonary Disease: Are B Cells the Frontrunners?
por: Ladjemi, Maha Zohra, et al.
Publicado: (2019)

Asthma and Chronic Obstructive Pulmonary Disease: Just Old Friends or Relatives?
por: Polverino, Francesca, et al.
Publicado: (2021)

B Cell–Adaptive Immune Profile in Emphysema-Predominant Chronic Obstructive Pulmonary Disease
por: Sullivan, John-Lawrence, et al.
Publicado: (2019)

Frontrunner in Translation: Progressive Supranuclear Palsy
por: Shoeibi, Ali, et al.
Publicado: (2019)

The Netherlands as frontrunner of collaborative research in adult congenital heart disease
por: Robbers-Visser, D., et al.
Publicado: (2016)

Genetic Susceptibility to Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis: The Missing Link?
por: Polverino, Francesca
Publicado: (2023)

“Frontrunners”: An Investigation of the Discursive Construction of “Women Politicians” Intersectional Identity
por: Milesi, Patrizia, et al.
Publicado: (2019)

Ataluren—Promising Therapeutic Premature Termination Codon Readthrough Frontrunner
por: Michorowska, Sylwia
Publicado: (2021)

Cardiovascular Disease and Chronic Obstructive Pulmonary Disease: Adding a Third Dimension to the ABE Global Initiative for Chronic Obstructive Lung Disease 2023 Chronic Obstructive Pulmonary Disease Classification
por: Kostikas, Konstantinos, et al.
Publicado: (2023)

Leveraging Omics to Predict Chronic Obstructive Pulmonary Disease Exacerbations: The “Immunome”
por: Polverino, Francesca, et al.
Publicado: (2023)

Biomarkers of Right Ventricular–Pulmonary Coupling in Chronic Obstructive Pulmonary Disease
por: Mehmood, Muddassir
Publicado: (2019)

Ultrasonography in Chronic Obstructive Pulmonary Disease: Fact or Fiction?
por: Alqahtani, Jaber S, et al.
Publicado: (2020)

Staphylococcus aureus enterotoxin A- and B-specific IgE in chronic obstructive pulmonary disease
por: Karakioulaki, Meropi, et al.
Publicado: (2023)

Ultrasonography of diaphragm in chronic obstructive pulmonary disease: Unanswered questions
por: Hadda, Vijay, et al.
Publicado: (2020)

Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
por: Vozoris, Nicholas T.
Publicado: (2021)

Health-related quality of life in chronic obstructive pulmonary disease
por: Rai, Deependra Kumar
Publicado: (2021)

Definition of Chronic Obstructive Pulmonary Disease: Occupational Environmental Contribution
por: Harber, Philip
Publicado: (2022)

Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
por: Mahler, Donald A., et al.
Publicado: (2020)

Pre–Chronic Obstructive Pulmonary Disease: Toward the Limits of the Spirometric Funnel
por: Wouters, Emiel F. M.
Publicado: (2021)

Exposing Pre–Chronic Obstructive Pulmonary Disease: When Physiology Matters!
por: Neder, J. Alberto, et al.
Publicado: (2021)

Asthma with a Smoking History and Pre–Chronic Obstructive Pulmonary Disease
por: Thomson, Neil C.
Publicado: (2021)

Malnutrition associated with readmission in elderly patients with chronic obstructive pulmonary disease
por: Zhao, Ting, et al.
Publicado: (2023)

Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs
por: Luyster, Faith S., et al.
Publicado: (2023)

Patients with Chronic Obstructive Pulmonary Disease Require More Than Pulmonary Rehabilitation to Improve Outcomes
por: Prieto-Centurion, Valentin, et al.
Publicado: (2019)

Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease
por: Mahler, Donald A.
Publicado: (2019)

Foreign Body Aspiration-induced Unusual Exacerbation of Chronic Obstructive Pulmonary Disease
por: Ren, Xiao-Xia, et al.
Publicado: (2016)

Cardiovascular and Chronic Obstructive Pulmonary Disease Therapeutics: Two Paths, One Destination?
por: Mehmood, Muddassir
Publicado: (2020)

The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2021)

Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
por: Mammen, Manoj J., et al.
Publicado: (2021)

Marijuana Use as a Risk Factor for Chronic Obstructive Pulmonary Disease: Not There Yet
por: Tashkin, Donald P., et al.
Publicado: (2023)

Rome Criteria for Exacerbation of Chronic Obstructive Pulmonary Disease: Not Built in a Day
por: Bhatt, Surya P.
Publicado: (2022)

Chronic Obstructive Pulmonary Disease Exacerbations: Do All Roads Lead to Rome?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2022)

Contributions of the voluntary local review process to policy integration: evidence from frontrunner cities
por: Ortiz-Moya, Fernando, et al.
Publicado: (2023)

Fibromax-based nonalcoholic fatty liver disease in chronic obstructive pulmonary disease patients with obstructive sleep apnea: Methodological considerations
por: Monneret, Denis
Publicado: (2017)

Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease, and Heart Failure with Preserved Ejection Fraction: A Cardiopulmonary Perspective
por: Mehmood, Muddassir
Publicado: (2020)

Integrated Therapy for Invasive Pulmonary Aspergillosis in a Patient with Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome
por: Shi, Ya-Qin, et al.
Publicado: (2015)

Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary Disease
por: Pouwels, Simon D., et al.
Publicado: (2019)

Acute exacerbation of chronic obstructive pulmonary disease treated by extracorporeal carbon dioxide removal
por: Li, Min, et al.
Publicado: (2019)

Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect
por: López-Campos, José Luis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9mfhgvf11j684epke0rmhtpmif